- Tytuł:
- EORTC-1203-GITCG - the 'INNOVATION'-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
- Autorzy:
- Temat:
-
Gastric cancer
Gastro-esophageal junction cancer
Perioperative chemotherapy
Trastuzumab
Pertuzumab
HER2
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282 - Źródło:
- BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
- Opis pliku:
- electronic resource
- Relacje:
- http://link.springer.com/article/10.1186/s12885-019-5675-4; https://doaj.org/toc/1471-2407
- Dostęp URL:
- https://doaj.org/article/868882dd5c1b417b8578bb744368f13f Link otwiera się w nowym oknie
Czasopismo naukowe